Stocks
Faro Raises $37.3M to Scale Agentic AI Across Clinical Development
Faro AI has secured $37.3 million in Series B funding to scale its agentic AI platform across clinical development.
The round was co-led by Merck Global Health Innovation Fund and S32, with participation from all existing investors.
The financing will be used to expand Faro's capabilities and accelerate the work of pharmaceutical and biotechnology companies deploying AI agents in their development organizations.
Faro has developed proprietary clinical development data models that translate complex concepts into structured intent, allowing AI systems to reason across clinical processes and automate workflows.